The presence of GLP-1 receptors in these reward pathways has prompted researchers to investigate whether GLP-1 agonists might influence behaviours beyond eating, including alcohol consumption
While also not prescribing GLP-1s personally, Brandon Peters, MD, FAASM, a sleep physician at Virginia Mason Medical Center, has patients taking GLP-1s for obesity or diabetes and seeing improvements in their OSA
The application, renewal, and CME tracking become complex fast
The manufacturing infrastructure advantage The largest Chinese peptide manufacturers operate facilities ranging from 1,000 square meters to over 50,000 square meters
TRIUMPH-4 Phase 3 trial Retatrutide and osteoarthritis outcomes
It is important to follow the dosing schedule as set out by your prescriber